INSULYNC: Changing the way diabetes is treated

Project description

Machine learning-based platform for the management of diabetes

Fields of science

• medical and health sciences › health sciences › health care services › eHealth
• natural sciences › computer and information sciences › internet › internet of things
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• medical and health sciences › clinical medicine › endocrinology › diabetes
• natural sciences › computer and information sciences › artificial intelligence › machine learning

Programme(s)

• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Topic(s)

• SMEInst-01-2016-2017 - Open Disruptive Innovation Scheme

Call for proposal

H2020-SMEInst-2016-2017

See other projects for this call

Sub call

H2020-SMEINST-1-2016-2017

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

MEDILYNC EHF

Net EU contribution

€ 50 000,00

Address

Hilmisgata 4
900 Vestmannaeyjar
Iceland

Region

Ísland › Ísland › Landsbyggð

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 21 429,00